<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8722753</article-id>
    <article-id pub-id-type="pmid">34406360</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btab591</article-id>
    <article-id pub-id-type="publisher-id">btab591</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Data and Text Mining</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Amanida: an R package for meta-analysis of metabolomics non-integral data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Llambrich</surname>
          <given-names>Maria</given-names>
        </name>
        <xref rid="btab591-cor1" ref-type="corresp"/>
        <aff><institution>Department of Electrical Electronic Engineering and Automation, Universitat Rovira i Virgili, IISPV</institution>, 43007 Tarragona, <country country="ES">Spain</country></aff>
        <aff><institution>Metabolomics Interdisciplinary Group, Department of Nutrition and Metabolism, Institut d’Investigació Sanitària Pere Virgili</institution>, 43201 Reus, Catalonia, <country country="ES">Spain</country></aff>
        <aff><institution>Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), ISCIII</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
        <!--maria.llambrich@urv.cat-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Correig</surname>
          <given-names>Eudald</given-names>
        </name>
        <aff><institution>Department of Biostatistics, Universitat Rovira i Virgili</institution>, 43201 Reus, Catalonia, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gumà</surname>
          <given-names>Josep</given-names>
        </name>
        <aff><institution>Oncology Department, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili</institution>, 43204 Reus, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brezmes</surname>
          <given-names>Jesús</given-names>
        </name>
        <aff><institution>Department of Electrical Electronic Engineering and Automation, Universitat Rovira i Virgili, IISPV</institution>, 43007 Tarragona, <country country="ES">Spain</country></aff>
        <aff><institution>Metabolomics Interdisciplinary Group, Department of Nutrition and Metabolism, Institut d’Investigació Sanitària Pere Virgili</institution>, 43201 Reus, Catalonia, <country country="ES">Spain</country></aff>
        <aff><institution>Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), ISCIII</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Cumeras</surname>
          <given-names>Raquel</given-names>
        </name>
        <xref rid="btab591-cor1" ref-type="corresp"/>
        <aff><institution>Department of Electrical Electronic Engineering and Automation, Universitat Rovira i Virgili, IISPV</institution>, 43007 Tarragona, <country country="ES">Spain</country></aff>
        <aff><institution>Metabolomics Interdisciplinary Group, Department of Nutrition and Metabolism, Institut d’Investigació Sanitària Pere Virgili</institution>, 43201 Reus, Catalonia, <country country="ES">Spain</country></aff>
        <aff><institution>Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), ISCIII</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
        <aff>
          <institution> West Coast Metabolomics Center, University of California Davis, CA 95616, USA</institution>
        </aff>
        <!--raquel.cumeras@urv.cat-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Wren</surname>
          <given-names>Jonathan</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btab591-cor1">To whom correspondence should be addressed. <email>maria.llambrich@urv.cat</email> or <email>raquel.cumeras@urv.cat</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-08-18">
      <day>18</day>
      <month>8</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>8</month>
      <year>2021</year>
    </pub-date>
    <volume>38</volume>
    <issue>2</issue>
    <fpage>583</fpage>
    <lpage>585</lpage>
    <history>
      <date date-type="received">
        <day>20</day>
        <month>5</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>03</day>
        <month>8</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>11</day>
        <month>8</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>16</day>
        <month>8</month>
        <year>2021</year>
      </date>
      <date date-type="corrected-typeset">
        <day>16</day>
        <month>9</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btab591.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>The combination, analysis and evaluation of different studies which try to answer or solve the same scientific question, also known as a meta-analysis, plays a crucial role in answering relevant clinical relevant questions. Unfortunately, metabolomics studies rarely disclose all the statistical information needed to perform a meta-analysis. Here, we present a meta-analysis approach using only the most reported statistical parameters in this field: <italic toggle="yes">P</italic>-value and fold-change. The <italic toggle="yes">P</italic>-values are combined via Fisher’s method and fold-changes by averaging, both weighted by the study size (<italic toggle="yes">n</italic>). The amanida package includes several visualization options: a volcano plot for quantitative results, a vote plot for total regulation behaviours (up/down regulations) for each compound, and a explore plot of the vote-counting results with the number of times a compound is found upregulated or downregulated. In this way, it is very easy to detect discrepancies between studies at a first glance.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>Amanida code and documentation are at CRAN and <ext-link xlink:href="https://github.com/mariallr/amanida" ext-link-type="uri">https://github.com/mariallr/amanida</ext-link>.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Spanish MINECO project Total2DChrom</institution>
          </institution-wrap>
        </funding-source>
        <award-id>RTI2018-098577-B-C21</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Catalan AGAUR project</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2018LLAV00072</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Marie Sklodowska-Curie grant</institution>
          </institution-wrap>
        </funding-source>
        <award-id>798038</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>URV PMF-PIPF program</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2019PMF-PIPF-37</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>AGAUR consolidated group</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2017 SGR 1119</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>CERCA Programme/Generalitat de Catalunya</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>COST Action</institution>
          </institution-wrap>
        </funding-source>
        <award-id>805 CA17118</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>COST (European Cooperation in Science and Technology</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>The widespread of metabolomics as a potential tool for clinical diagnosis has increased the systematic reviews and meta-analysis on this topic. Meta-analysis is the statistical combination in a single estimate for results from primary studies answering the same question, which is a common practice in medical research. Typical protocols for meta-analysis only consider one metric to conduct the analysis, whether statistical significance or relative change. They require raw data [Metaboanalyst’ (<xref rid="btab591-B3" ref-type="bibr">Chong <italic toggle="yes">et al.</italic>, 2018</xref>)] or statistics parameters like standard error, standard deviation or variance [R package ‘meta’ (<xref rid="btab591-B1" ref-type="bibr">Balduzzi <italic toggle="yes">et al.</italic>, 2019</xref>)], rarely disclosed in metabolomics studies (<xref rid="btab591-B10" ref-type="bibr">Lee <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btab591-B20" ref-type="bibr">Tofte <italic toggle="yes">et al.</italic>, 2020</xref>). This causes that in some cases about half of the studies on systematic reviews are not suitable to be included in the meta-analysis (<xref rid="btab591-B6" ref-type="bibr">Guasch-Ferré <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btab591-B14" ref-type="bibr">Pang <italic toggle="yes">et al.</italic>, 2021</xref>). Although some standardizations have been proposed for the chemical analysis of metabolomics experiments (sample preparation, experimental analysis, quality control, metabolite identification and data pre-processing) (<xref rid="btab591-B19" ref-type="bibr">Sumner <italic toggle="yes">et al.</italic>, 2007</xref>), clinical metabolomics needs standardized statistical reporting (<xref rid="btab591-B13" ref-type="bibr">Mutter <italic toggle="yes">et al.</italic>, 2019</xref>) including how to process meta-analysis. Also, metabolomics public repositories, such as MetaboLights (<xref rid="btab591-B7" ref-type="bibr">Haug <italic toggle="yes">et al.</italic>, 2020</xref>), do not disclose the statistics data for all studies. On this matter, some approaches have been developed when the studies to be included for meta-analysis do not disclose statistical data, such as vote-counting (<xref rid="btab591-B2" ref-type="bibr">Bushman and Wang, 2009</xref>), a qualitative estimate that takes into account only the trend of the compound. Some omics have high established protocols for meta-analysis, i.e. microarray in genomics, although the last improvements these methods cannot be adapted to metabolomics as they require the same genes or probes between studies and/or mean per group with standard deviation (<xref rid="btab591-B9" ref-type="bibr">Huo <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btab591-B12" ref-type="bibr">Marot <italic toggle="yes">et al.</italic>, 2009</xref>), which is not the case for metabolomics, due to the different analytical techniques used. In this omics, standards protocols only recommend to disclose the overall result of the univariate analysis, <italic toggle="yes">P</italic>-value and fold-change, without the need of reporting deviation or other metrics (<xref rid="btab591-B22" ref-type="bibr">Viant <italic toggle="yes">et al.</italic>, 2019</xref>).</p>
    <p>Public meta-analysis tools can only by applied to data with standard deviation or directly to raw data (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). Currently there is no available methodology to do a meta-analysis based on studies that only disclose overall results. Amanida addresses the issue of combining overall results to perform meta-analysis based on statistical significance (<italic toggle="yes">P</italic>-value), relative change (fold-change) and study size. This approach increases the power of meta-analysis in metabolomics where the relative change is as important as the statistical significance (<xref rid="btab591-B18" ref-type="bibr">Sinclair and Dudley, 2019</xref>; <xref rid="btab591-B21" ref-type="bibr">Tolstikov <italic toggle="yes">et al.</italic>, 2020</xref>). Estimates are weighted by study size to give more value to big studies where results are less overfitted or spurious (<xref rid="btab591-B17" ref-type="bibr">Rattray <italic toggle="yes">et al.</italic>, 2018</xref>). Amanida R package also includes the option of performing a qualitative vote-counting plot, as many metabolomics studies will only report the relative change trend, and in this case, only a systematic review can be performed.</p>
  </sec>
  <sec>
    <title>2 Statistical information</title>
    <p>For significance evaluation using the statistic result <italic toggle="yes">P</italic>-value, we use the weighted <italic toggle="yes">P</italic>-values combination (<xref rid="btab591-B23" ref-type="bibr">Yoon <italic toggle="yes">et al.</italic>, 2021</xref>), which is a variant of Fisher’s method (<xref rid="btab591-B5" ref-type="bibr">Fisher, 1925</xref>). A gamma distribution is used to assign non-integral weights proportional to study size to each <italic toggle="yes">P</italic>-value (1).
<disp-formula id="E1"><label>(1)</label><mml:math id="M1" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">combined</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Γ</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal"> </mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:mfenced><mml:mi mathvariant="normal"> </mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">k</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">X</mml:mi><mml:mo>;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">df</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="normal">df</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">k</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mi mathvariant="normal"> </mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:math></disp-formula></p>
    <p>The fold-change is logarithmically transformed (base 2) to reduce skewness due to methodology (<xref rid="btab591-B4" ref-type="bibr">Curran-Everett, 2018</xref>), so that the variability is more homogeneous, and the distribution of the sample mean is consistent with a normal distribution. The logarithmically transformed fold-change values are averaged with weighting by study size (2).
<disp-formula id="E2"><label>(2)</label><mml:math id="M2" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi mathvariant="normal">FC</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">combined</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi mathvariant="normal">k</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">FC</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi mathvariant="normal">k</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:math></disp-formula></p>
    <p>Missing data are ignored, and negative values fold-change which stands for inverse comparison (control/case), are reversed (-1/value).</p>
    <p>A qualitative analysis of the data can be performed with a vote-counting approach. Vote-counting comprises the general behaviour of the metabolites per study. As previously described (<xref rid="btab591-B2" ref-type="bibr">Bushman and Wang, 2009</xref>), votes are assigned as follows: value of +1 for compounds up-regulated, value of -1 for down-regulated, and 0 if no change in the behaviour is reported. Then, the total vote per compound is obtained summing the votes.</p>
  </sec>
  <sec>
    <title>3 Software description</title>
    <p>The Amanida R package allows a meta-analysis of metabolomics data, combining the results of different studies addressing the same question. The user provides the input data through text files (in txt, csv or xlsx format) containing the following information: identifier (previously curated by the user), <italic toggle="yes">P</italic>-value, fold-change, study size (N) and reference. Then amanida computes the quantitative and qualitative meta-analysis. Results are disclosed in two tables, one for the quantitative meta-analysis, with the global <italic toggle="yes">P</italic>-value and fold-change obtained, and one for the qualitative meta-analysis, with the vote-counting and number of articles.</p>
    <p>Results can be graphically inspected via different plots: the volcano_plot where <italic toggle="yes">P</italic>-value and fold-change are plotted in logarithmic scale (see <xref rid="btab591-F1" ref-type="fig">Fig. 1</xref>), for which the user can select the cut-off thresholds, labelling the selected compounds with their identifiers; the vote_plot where the vote-counting results are plotted per each compound; and the explore_plot where the vote-counting results are plotted against the total number of articles in which each compound is reported as upregulated or downregulated (see <xref rid="btab591-F2" ref-type="fig">Fig. 2</xref>). All analysis can be obtained in a completely automatic manner using amanida_report function. To illustrate the package we have used a dataset from a urinary metabolomics meta-analysis study of colorectal cancer (<xref rid="btab591-B11" ref-type="bibr">Mallafré <italic toggle="yes">et al.</italic>, 2021</xref>).</p>
    <fig position="float" id="btab591-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>Amanida volcano plot. Quantitative meta-analysis results with a cut-off of 0.05 for <italic toggle="yes">P</italic>-value and 3 for fold-change. Data obtained from (<xref rid="btab591-B11" ref-type="bibr">Mallafré <italic toggle="yes">et al.</italic>, 2021</xref>)</p>
      </caption>
      <graphic xlink:href="btab591f1" position="float"/>
    </fig>
    <fig position="float" id="btab591-F2">
      <label>Fig. 2.</label>
      <caption>
        <p>Amanida explore plot. Vote-counting results plotted against total number of articles divided by trend. Data obtained from (<xref rid="btab591-B11" ref-type="bibr">Mallafré <italic toggle="yes">et al.</italic>, 2021</xref>)</p>
      </caption>
      <graphic xlink:href="btab591f2" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>4 Validation</title>
    <p>To evaluate the package, we selected a metabolomics meta-analysis with data disclosed (<xref rid="btab591-B10" ref-type="bibr">Lee <italic toggle="yes">et al.</italic>, 2020</xref>) which describes the association of metabolites with lung cancer risk. We could only use the information of amino acids concentration disclosed in six studies to compare both methodologies, as it was the only fully available (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>). We must mention that to include the original six studies as in Lee <italic toggle="yes">et al.</italic> from one study the numeric values have been extracted directly from box-plots (<xref rid="btab591-B15" ref-type="bibr">Pietzke <italic toggle="yes">et al.</italic>, 2019</xref>). The meta-analysis used on the reviews compares the weighted means between groups using the fixed model or random model if there is high heterogeneity (<italic toggle="yes">I</italic><sup>2</sup> &gt; 40%) between studies. The principal difference is that the fixed model assumes the effect in all studies is the same and the random model assumes that the effects between studies vary according to a normal distribution, used for convention. When there is high heterogeneity between studies with random models the studies are weighted more equally, this gives higher weight to small studies which is an unwanted approximation in metabolomics. Regarding results, Lee <italic toggle="yes">et al.</italic> found three statistically significant compounds associated with lung cancer risk: Methionine (<italic toggle="yes">I</italic><sup>2</sup> = 86.0%), Proline (<italic toggle="yes">I</italic><sup>2</sup> = 87.1%) and Tryptophan (<italic toggle="yes">I</italic><sup>2</sup> = 83.6%). Following the same procedure, we have repeated the meta-analysis using the ‘Meta’ R package (<xref rid="btab591-B1" ref-type="bibr">Balduzzi <italic toggle="yes">et al.</italic>, 2019</xref>). We obtained significant results (see Supplementary Figs) for Proline [random model (I^2 = 87.1%)]. Differences in the results are due to the difference in the box-plot estimations from (<xref rid="btab591-B15" ref-type="bibr">Pietzke <italic toggle="yes">et al.</italic>, 2019</xref>).</p>
    <p>We applied the amanida approach to the same data as Lee <italic toggle="yes">et al.</italic> for amino acids, where 20 of the 21 amino acids achieve statistical significance (<italic toggle="yes">P</italic>-value combined &lt; 0.05, <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>), however the fold-change combined in all cases is smaller than 1.5, far from the threshold of 2 to consider a biological change. This means it might be a pattern in the amino acids of lung cancer patients, but the biological effect is small.</p>
    <p>Evaluation of meta-analysis results includes multiple metrics including the multiple steps of processing applied compound by compound, while amanida results are obtained straightforward in a detailed report. As mentioned before, amanida has the advantage to work with <italic toggle="yes">P</italic>-values and fold-change, metrics more disclosed in metabolomics studies than the compound concentrations with their deviations. Also, it increases the readability of the results, classical meta-analysis includes multiple parameters to consider, such as heterogeneity, ranks or multiple models to obtain relevant results. We must say that Lee <italic toggle="yes">et al.</italic> considered as good metabolites, those with extremely high heterogeneity, and that Cochrane recommends not to do meta-analysis when considerable variation of results, i.e. <italic toggle="yes">I</italic><sup>2</sup> is 75–100% (<xref rid="btab591-B8" ref-type="bibr">Higgins <italic toggle="yes">et al.</italic>, 2019</xref>). The validation study used, was the only one that the authors found that reported both mean differences and standard deviations along with <italic toggle="yes">P</italic>-values and fold-changes.</p>
  </sec>
  <sec>
    <title>5 Limitations</title>
    <p>Applying amanida meta-analysis directly to the statistical estimates reduces the combination accuracy since without the raw data is not possible to know how much dispersion there is or how many outliers are included. Another drawback is found when the studies only disclose the statistical information for the significant compounds whereas preventing the correct combination of all results. Good practices in metabolomics suggest using a minimum of 50 samples per group to obtain relevant results, in a meta-analysis, these small studies are not recommended to be included due to the variability introduced, as we can observe with <xref rid="btab591-B16" ref-type="bibr">Proenza <italic toggle="yes">et al.</italic>’s (2003)</xref> and <xref rid="btab591-B24" ref-type="bibr">Yue <italic toggle="yes">et al.</italic>’s (2018)</xref> studies which have 14 and 20 participants per group, respectively. A common criticism for all meta-analyses described in Cochrane Handbook is that they ‘combine apples with oranges’ (<xref rid="btab591-B8" ref-type="bibr">Higgins <italic toggle="yes">et al.</italic>, 2019</xref>), which have been also said for metabolomics as there is a wide range of techniques for compound detection or extraction methods with different sensibility that are combined. This limitation can be restricted on the systematic search, selecting only studies with the same technique and protocol, but it will reduce substantially the number of studies to combine.</p>
  </sec>
  <sec>
    <title>6 Summary</title>
    <p>\Amanida has been developed to deal with two issues, the few data disclosed in metabolomics and attribute different weights for the studies according to sample size. Standards metabolomics protocols basically recommend to disclose the overall result of the analysis, <italic toggle="yes">P</italic>-value and fold-change, without the need of reporting their means or deviation or other metrics (used in classical meta-analysis). In amanida, both overall statistical results are weighted according to the sample size, where larger studies will have more importance. Classical meta-analysis does not measure the strength of the combined result, only shows if the data has a pattern. To look for the strength we combine the statistical significance (<italic toggle="yes">P</italic>-value) with the effect (fold-change), which measures the quantity of change between groups. Amanida is the first approach to a meta-analysis with non-integral data.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btab591_Supplementary_Data</label>
      <media xlink:href="btab591_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgement</title>
    <p>The authors thank Dr Mariona Vinaixa (Universitat Rovira i Virgili, Spain) for the many useful discussions and helpful suggestions.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by Spanish MINECO project Total2DChrom [RTI2018-098577-B-C21] and Catalan AGAUR project [2018LLAV00072]. This project received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No [798038]. M.LL. is thankful for her graduate fellowship from URV PMF-PIPF program [ref. 2019PMF-PIPF-37]. They acknowledge the AGAUR consolidated group [2017 SGR 1119]. IISPV is a member of the CERCA Programme/Generalitat de Catalunya. This article is based upon work from COST Action 805 CA17118, supported by COST (European Cooperation in Science and Technology).</p>
      <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btab591-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balduzzi</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>How to perform a meta-analysis with R: a practical tutorial</article-title>. <source>Evid. Based Ment. Health</source>, <volume>22</volume>, <fpage>153</fpage>–<lpage>160</lpage>.<pub-id pub-id-type="pmid">31563865</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bushman</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M.C.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Vote-counting procedures in meta-analysis</article-title>. In: <italic toggle="yes">The Handbook of Research Synthesis and Meta-Analysis</italic>. New York, Russel Sage Foundation. pp. <fpage>207</fpage>–<lpage>220</lpage>.</mixed-citation>
    </ref>
    <ref id="btab591-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chong</surname><given-names>J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>W486</fpage>–<lpage>W494</lpage>.<pub-id pub-id-type="pmid">29762782</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Curran-Everett</surname><given-names>D.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Explorations in statistics: the log transformation</article-title>. <source>Adv. Physiol. Educ</source>., <volume>42</volume>, <fpage>343</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">29761718</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B5">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Fisher</surname><given-names>R.</given-names></string-name></person-group> (<year>1925</year>) <italic toggle="yes">Statistical Methods for Research Workers<italic toggle="yes">,</italic> <italic toggle="yes">1st edn</italic></italic>. Oliver and Boyd, Edinburgh, Scotland.</mixed-citation>
    </ref>
    <ref id="btab591-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guasch-Ferré</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis</article-title>. <source>Diabetes Care</source>, <volume>39</volume>, <fpage>833</fpage>–<lpage>846</lpage>.<pub-id pub-id-type="pmid">27208380</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haug</surname><given-names>K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>MetaboLights: a resource evolving in response to the needs of its scientific community</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>D440</fpage>–<lpage>D444</lpage>.<pub-id pub-id-type="pmid">31691833</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B8">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Higgins</surname><given-names>J.P.T.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <italic toggle="yes">Cochrane Handbook for Systematic Reviews of Interventions</italic>, 2nd edn. Wiley.</mixed-citation>
    </ref>
    <ref id="btab591-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huo</surname><given-names>Z.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>P-value evaluation, variability index and biomarker categorization for adaptively weighted Fisher’s meta-analysis method in omics applications</article-title>. <source>Bioinformatics</source>, <volume>36</volume>, <fpage>524</fpage>–<lpage>532</lpage>.<pub-id pub-id-type="pmid">31359040</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>K.B.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Association between metabolites and the risk of lung cancer: a systematic literature review and meta-analysis of observational studies</article-title>. <source>Metabolites</source>, <volume>10</volume>, <fpage>1</fpage>–<lpage>30</lpage>.</mixed-citation>
    </ref>
    <ref id="btab591-B11">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Mallafré</surname><given-names>C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) Comprehensive volatilome and metabolome signatures of colorectal cancer in urine: a systematic review and meta-analysis. <italic toggle="yes">Cancers,</italic><bold>13</bold>, 2534.</mixed-citation>
    </ref>
    <ref id="btab591-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marot</surname><given-names>G.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2009</year>) <article-title>Moderated effect size and P-value combinations for microarray meta-analyses</article-title>. <source>Bioinformatics</source>, <volume>25</volume>, <fpage>2692</fpage>–<lpage>2699</lpage>.<pub-id pub-id-type="pmid">19628502</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mutter</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Statistical reporting of metabolomics data: experience from a high-throughput NMR platform and epidemiological applications</article-title>. <source>Metabolomics</source>, <volume>16</volume>, <fpage>5</fpage>.<pub-id pub-id-type="pmid">31823035</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pang</surname><given-names>Z.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>Comprehensive meta-analysis of COVID-19</article-title>. <source>Global Metab. Datasets Metab</source>., <volume>11</volume>, <fpage>44</fpage>.</mixed-citation>
    </ref>
    <ref id="btab591-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pietzke</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal>; On behalf of the METTEN Study Group. (<year>2019</year>) <article-title>Stratification of cancer and diabetes based on circulating levels of formate and glucose</article-title>. <source>Cancer Metab</source>., <volume>7</volume>, <fpage>3</fpage>.<pub-id pub-id-type="pmid">31049200</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Proenza</surname><given-names>A.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2003</year>) <article-title>Breast and lung cancer are associated with a decrease in blood cell amino acid content</article-title>. <source>J. Nutr. Biochem</source>., <volume>14</volume>, <fpage>133</fpage>–<lpage>138</lpage>.<pub-id pub-id-type="pmid">12742540</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rattray</surname><given-names>N.J.W.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Beyond genomics: understanding exposotypes through metabolomics</article-title>. <source>Hum. Genomics</source>, <volume>12</volume>, <fpage>4</fpage>.<pub-id pub-id-type="pmid">29373992</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sinclair</surname><given-names>K.</given-names></string-name>, <string-name><surname>Dudley</surname><given-names>E.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Metabolomics and biomarker discovery</article-title>. <source>Adv. Exp. Med. Biol</source>., <volume>1140</volume>, <fpage>613</fpage>–<lpage>633</lpage>.<pub-id pub-id-type="pmid">31347075</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sumner</surname><given-names>L.W.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2007</year>) <article-title>Proposed minimum reporting standards for chemical analysis: chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)</article-title>. <source>Metabolomics</source>, <volume>3</volume>, <fpage>211</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">24039616</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tofte</surname><given-names>N.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Plasma metabolomics identifies markers of impaired renal function: a meta-analysis of 3089 persons with type 2 diabetes</article-title>. <source>J. Clin. Endocrinol. Metab</source>., <volume>105</volume>, <fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">31511876</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tolstikov</surname><given-names>V.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Current status of metabolomic biomarker discovery: impact of study design and demographic characteristics</article-title>. <source>Metabolites</source>, <volume>10</volume>, <fpage>224</fpage>.<pub-id pub-id-type="pmid">32485899</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Viant</surname><given-names>M.R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Use cases, best practice and reporting standards for metabolomics in regulatory toxicology</article-title>. <source>Nat. Commun</source>, <volume>10</volume>, <fpage>3041</fpage>.<pub-id pub-id-type="pmid">31292445</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yoon</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>Powerful p-value combination methods to detect incomplete association</article-title>. <source>Sci. Rep</source>., <volume>11</volume>, <fpage>6980</fpage>.<pub-id pub-id-type="pmid">33772054</pub-id></mixed-citation>
    </ref>
    <ref id="btab591-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yue</surname><given-names>X.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites</article-title>. <source>J. Chromatogr. A</source>, <volume>1580</volume>, <fpage>80</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">30473010</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
